The molecular basis for the anti-inflammatory property of intravenous gamma
globulin (IVIG) was investigated in a murine model of immune thrombocytope
nia. Administration of clinically protective doses of intact antibody or mo
nomeric Fe fragments to wild-type or Fc gamma receptor-humanized mice preve
nted platelet consumption triggered by a pathogenic autoantibody. The inhib
itory Pc receptor, Fc gamma RIIB, was required for protection, because disr
uption either by genetic deletion or with a blocking monoclonal antibody re
versed the therapeutic effect of IVIG. Protection was associated with the a
bility of IVIG administration to induce surface expression of Fc gamma RIIB
on splenic macrophages. Modulation of inhibitory signaling is thus a poten
t therapeutic strategy for attenuating autoantibody-triggered inflammatory
diseases.